The Investment Dilemma: The “Must-Play” Game of the Era. AI has emerged as the defining strategic priority and a primary target for capital allocation across industries. From pharmaceuticals to retail, companies are aggressively deploying Generative AI and automation at a
Continue Reading
Antibody-Drug Conjugates (ADCs) are among the most promising precision therapies today. By combining the high targeting capability of monoclonal antibodies with the potent cytotoxicity of small-molecule drugs, they have become a new focal point in the R&D of cancer and
Continue Reading
The wave of AI is accelerating the transformation of the global pharmaceutical industry. AI startup therapiAI announced today (Feb 9) the completion of a Phase 1 AI Proof of Concept (POC) with Panlabs, a world-class leader in biotechnology. Focusing on
Continue Reading
The New Game for CDMOs: Shifting from Capacity Scale to Knowledge Capabilities The pharmaceutical CDMO industry is currently navigating an unprecedented wave of transformation. Over the past two years, multiple industry reports have consistently indicated that the competitive threshold has
Continue Reading
Taiwanese AI drug discovery startup TherapiAI, in collaboration with the Development Center for Biotechnology (DCB), recently hosted the “Empowering with AI Agents: Data Transformation and Pharmaceutical Innovation” industry forum. The event centered on the practical application and implementation of AI
Continue Reading
TherapiAI Partners with 100+ Global Pharma Firms at Tokyo Expo to Launch International Expansion Enhancing R&D Efficiency and Compliance Management for Pharmaceutical Companies with an AI Agent Decision Platform. Deepening Taiwan-Japan Collaboration to Establish the APAC Market as the Infrastructure
Continue Reading
Article Categories
Article Categories
Article Categories
Latest Articles
Follow Us
